Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: Tools for matching patients and protocols

Reproductive Biology and Endocrinology

Volumn 10, Issue , 2012, Pages

  Alviggi, Carlo ^a   Humaidan, Peter ^b   Ezcurra, Diego ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c MERCK SERONO S A   (Switzerland)

Author keywords

Biomarkers; Controlled ovarian stimulation; Genetic screening; Personalised

Indexed keywords

BIOLOGICAL MARKER; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADOTROPIN; GONADOTROPIN DERIVATIVE; INHIBIN B; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MUELLERIAN INHIBITING FACTOR; PRASTERONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE; GONADORELIN;

AGE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED OVARIAN STIMULATION; DRUG SAFETY; DRUG TOLERABILITY; GENETIC SCREENING; GENOTYPE; HUMAN; INFERTILITY THERAPY; OVARIAN RESERVE; PREDICTION; PROGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THERAPY EFFECT; ADULT; BLOOD; DRUG POTENTIATION; FEMALE; FEMALE INFERTILITY; GENETIC POLYMORPHISM; GENETICS; METHODOLOGY; OVARY FOLLICLE; OVULATION INDUCTION; PERSONALIZED MEDICINE; PHYSIOLOGY;

ADULT; AGE FACTORS; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INDIVIDUALIZED MEDICINE; INFERTILITY, FEMALE; OVARIAN FOLLICLE; OVULATION INDUCTION; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, FSH; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 84856565411     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-10-9     Document Type: Review

References (46)

1. Ezcurra D, Bosch E. Individualised controlled ovarian simulation (iCOS): maximising success rates for assisted reproductive technology patients. Reprod Biol Endocrinol 2011, 21. 9:82.
2. Baker JW, Morgan RL, Peckham MJ, Smithers DW. Preservation of ovarian function in patients requiring radiotherapy for para-aortic and pelvic Hodgkin's disease. Lancet 1972, 1:1307-1308.
3. Akande VA, Fleming CF, Hunt LP, Keay SD, Jenkins JM. Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod 2002, 17:2003-2008. 10.1093/humrep/17.8.2003, 12151428.
4. La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS. Anti-Mullerian hormone (AMH): what do we still need to know?. Hum Reprod 2009, 24:2264-2275. 10.1093/humrep/dep210, 19520713.
5. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010, 16:113-130. 10.1093/humupd/dmp036, 19793843.
6. Gnoth C, Schuring AN, Friol K, Tigges J, Mallmann P, Godehardt E. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod 2008, 23:1359-1365. 10.1093/humrep/den108, 18387961.
7. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, Mitchell P, Ambrose P, Fleming R. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod 2009, 24:867-875.
8. Fréour T, Mirallié S, Bach-Ngohou K, Denis M, Barrière P, Masson D. Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta 2007, 375:162-4. 10.1016/j.cca.2006.06.013, 16860302.
9. Chang MY, Chiang CH, Chiu TH, Hsieh TT, Soong YK. The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program. J Assist Reprod Genet 1998, 15:12-17. 10.1023/A:1022518103368, 9493060.
10. Hendriks DJ, Mol BW, Bancsi LF, te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 2005, 83:291-301. 10.1016/j.fertnstert.2004.10.011, 15705365.
11. Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 1998, 69:505-510. 10.1016/S0015-0282(97)00557-8, 9531887.
12. Jayaprakasan K, Deb S, Batcha M, Hopkisson J, Johnson I, Campbell B, Raine-Fenning N. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Mullerian hormone and response to controlled ovarian stimulation. Fertil Steril 2010, 94:1775-1781. 10.1016/j.fertnstert.2009.10.022, 19931077.
13. Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril 2010, 94:1044-1051. 10.1016/j.fertnstert.2009.04.040, 19589513.
14. Howles CM, Saunders H, Alam V, Engrand P, . FSH Treatment Guidelines Clinical Panel Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients. Curr Med Res Opin 2006, 22:907-918. 10.1185/030079906X104678, 16709312, FSH Treatment Guidelines Clinical Panel.
15. Olivennes F, Howles CM, Borini A, Germond M, Trew G, Wikland M, Zegers-Hochschild F, Saunders H, Alam V. Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reprod Biomed Online 2009, 18:195-204. 10.1016/S1472-6483(10)60256-8, 19192339.
16. De Placido G, Mollo A, Alviggi C, Strina I, Varricchio MT, Ranieri A, Colacurci N, Tolino A, Wilding M. Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Hum Reprod 2001, 16:1875-1879. 10.1093/humrep/16.9.1875, 11527891.
17. De Placido G, Alviggi C, Mollo A, Strina I, Ranieri A, Alviggi E, Wilding M, Varricchio MT, Borrelli AL, Conforti S. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clin Endocrinol (Oxf) 2004, 60:637-643.
18. De Placido G, Clarizia R, Alviggi C. Lutropin alfa: a viewpoint by Giuseppe De Placido, Roberto Clarizia and Carlo Alviggi. Drugs 2008, 68:1541-1542.
19. Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Farfalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004, 82:1521-1526. 10.1016/j.fertnstert.2004.06.041, 15589853.
20. Liao WX, Goh HH, Roy AC. Functional characterization of a natural variant of luteinizing hormone. Hum Genet 2002, 111:219-224. 10.1007/s00439-002-0781-8, 12189497.
21. Huhtaniemi I, Pettersson K. Mutations and polymorphisms in the gonadotrophin genes; clinical relevance. Clin Endocrinol (Oxf) 1998, 48:675-682.
22. Jiang M, Pakarinen P, Zhang FP, El-Hefnawy T, Koskimies P, Pettersson K, Huhtaniemi I. A common polymorphic allele of the human luteinizing hormone beta-subunit gene: additional mutations and differential function of the promoter sequence. Hum Mol Genet 1999, 8:2037-2046. 10.1093/hmg/8.11.2037, 10484773.
23. Nilsson CH, Kaleva M, Virtanen H, Haavisto AM, Pettersson K, Huhtaniemi IT. Disparate response of wild-type and variant forms of LH to GnRH stimulation in individuals heterozygous for the LHbeta variant allele. Hum Reprod 2001, 16:230-235. 10.1093/humrep/16.2.230, 11157812.
24. Alviggi C, Clarizia R, Pettersen K, Mollo A, Humaidan P, Strina I, Coppola M, Ranieri A, D'Uva M, De Placido G. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online 2009, 18:9-14. 10.1016/S1472-6483(10)60418-X, 19146763.
25. Gromoll J, Lahrmann L, Godmann M, Muller T, Michel C, Stamm S, Simoni M. Genomic checkpoints for exon 10 usage in the luteinizing hormone receptor type 1 and type 2. Mol Endocrinol 2007, 21:1984-1996. 10.1210/me.2006-0506, 17505059.
26. Nordhoff V, Gromoll J, Simoni M. Constitutively active mutations of G protein-coupled receptors: the case of the human luteinizing hormone and follicle-stimulating hormone receptors. Arch Med Res 1999, 30:501-509. 10.1016/S0188-4409(99)00076-4, 10714364.
27. Akerman FM, Lei Z, Rao CV, Nakajima ST. A case of spontaneous ovarian hyperstimulation syndrome with a potential mutation in the hCG/LH receptor gene. Fertil Steril 2000, 74:403-404. 10.1016/S0015-0282(00)00628-2, 10927070.
28. Gromoll J, Simoni M. Genetic complexity of FSH receptor function. Trends Endocrinol Metab 2005, 16:368-373. 10.1016/j.tem.2005.05.011, 16126408.
29. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L, Simoni M. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 2005, 90:4866-4872. 10.1210/jc.2004-2268, 15886248.
30. Falconer H, Andersson E, Aanesen A, Fried G. Follicle-stimulating hormone receptor polymorphisms in a population of infertile women. Acta Obstet Gynecol Scand 2005, 84:806-811.
31. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, Seliger E, Ropke F, Gromoll J, Nieschlag E, Simoni M. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005, 15:451-456. 10.1097/01.fpc.0000167330.92786.5e, 15970792.
32. Gerasimova T, Thanasoula MN, Zattas D, Seli E, Sakkas D, Lalioti MD. Identification and in vitro characterization of follicle stimulating hormone (FSH) receptor variants associated with abnormal ovarian response to FSH. J Clin Endocrinol Metab 2010, 95:529-536. 10.1210/jc.2009-1304, 2840851, 20061434.
33. Manna PR, Joshi L, Reinhold VN, Aubert ML, Suganuma N, Pettersson K, Huhtaniemi IT. Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone. Hum Mol Genet 2002, 11:301-315. 10.1093/hmg/11.3.301, 11823449.
34. Nilsson C, Pettersson K, Millar RP, Coerver KA, Matzuk MM, Huhtaniemi IT. Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group. Fertil Steril 1997, 67:998-1004. 10.1016/S0015-0282(97)81430-6, 9176435.
35. Alviggi C, Clarizia R, Pettersson K, Mollo A, Strina I, De Biasio G, De Placido G, Humaidan P. A single point mutation in the LH beta subunit is associated with higher exogenous FSH consumption during ovarian stimulation. Human Reprod 2009, 24(Suppl 1):i31. abstract O-077.
36. Lalioti MD. Impact of follicle stimulating hormone receptor variants in fertility. Curr Opin Obstet Gynecol 2011, 23:158-167. 10.1097/GCO.0b013e3283455288, 21372710.
37. Simoni M, Gromoll J, Höppner W, Kamischke A, Krafft T, Stähle D, Nieschlag E. Mutational analysis of the follicle-stimulating hormone receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 1999, 84:751-755. 10.1210/jc.84.2.751, 10022448.
38. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000, 85:3365-3369. 10.1210/jc.85.9.3365, 10999835.
39. Gu BH, Park JM, Baek KH. Genetic variations of follicle stimulating hormone receptor are associated with polycystic ovary syndrome. Int J Mol Med 2010, 26:107-112.
40. Valkenburg O, Uitterlinden AG, Piersma D, Hofman A, Themmen AP, de Jong FH, Fauser BC, Laven JS. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum Reprod 2009, 24:2014-2022. 10.1093/humrep/dep113, 19403562.
41. Overbeek A, Kuijper EA, Hendriks ML, Blankenstein MA, Ketel IJ, Twisk JW, Hompes PG, Homburg R, Lambalk CB. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod 2009, 24:2007-2013. 10.1093/humrep/dep114, 19401323.
42. Mohiyiddeen L, Nardo LG. Single-nucleotide polymorphisms in the FSH receptor gene and ovarian performance: future role in IVF. Hum Fertil (Camb) 2010, 13:72-78.
43. Jun JK, Yoon JS, Ku SY, Choi YM, Hwang KR, Park SY, Lee GH, Lee WD, Kim SH, Kim JG, Moon SY. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet 2006, 51:665-670. 10.1007/s10038-006-0005-5, 16871362.
44. Klinkert ER, te Velde ER, Weima S, van Zandvoort PM, Hanssen RG, Nilsson PR, de Jong FH, Looman CW, Broekmans FJ. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online 2006, 13:687-695. 10.1016/S1472-6483(10)60660-8, 17169182.
45. Detti L, Williams DB, Robins JC, Maxwell RA, Thomas MA. A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization. Fertil Steril 2005, 84:1401-1405. 10.1016/j.fertnstert.2005.04.053, 16275235.
46. Loutradis D, Vomvolaki E, Drakakis P. Poor responder protocols for in-vitro fertilization: options and results. Curr Opin Obstet Gynecol 2008, 20:374-378. 10.1097/GCO.0b013e328305b9b8, 18660689.